Clearmind Medicine Common Stock Probability of Future Stock Price Finishing Over 19.58
| CMND Stock | USD 1.33 0.10 6.99% |
Clearmind |
Clearmind Medicine Target Price Odds to finish over 19.58
The tendency of Clearmind Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 19.58 or more in 90 days |
| 1.33 | 90 days | 19.58 | close to zero percent |
Based on a normal probability distribution, the odds of Clearmind Medicine to move over $ 19.58 or more in 90 days from now is close to zero percent (This Clearmind Medicine Common probability density function shows the probability of Clearmind Stock to fall within a particular range of prices over 90 days) . Probability of Clearmind Medicine Common price to stay between its current price of $ 1.33 and $ 19.58 at the end of the 90-day period is about 60.75 .
Given the investment horizon of 90 days Clearmind Medicine Common has a beta of -0.42 suggesting as returns on the benchmark increase, returns on holding Clearmind Medicine are expected to decrease at a much lower rate. During a bear market, however, Clearmind Medicine Common is likely to outperform the market. Additionally Clearmind Medicine Common has an alpha of 0.1578, implying that it can generate a 0.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Clearmind Medicine Price Density |
| Price |
Predictive Modules for Clearmind Medicine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clearmind Medicine Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Clearmind Medicine Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Clearmind Medicine is not an exception. The market had few large corrections towards the Clearmind Medicine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Clearmind Medicine Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Clearmind Medicine within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.16 | |
β | Beta against Dow Jones | -0.42 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.0008 |
Clearmind Medicine Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clearmind Medicine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clearmind Medicine Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Clearmind Medicine had very high historical volatility over the last 90 days | |
| Clearmind Medicine may become a speculative penny stock | |
| Clearmind Medicine has a very high chance of going through financial distress in the upcoming years | |
| Clearmind Medicine Common currently holds 3.61 M in liabilities. Clearmind Medicine Common has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Clearmind Medicine's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Clearmind Medicine Common currently holds about 1.65 K in cash with (4.56 M) of positive cash flow from operations. | |
| Clearmind Medicine has a frail financial position based on the latest SEC disclosures |
Clearmind Medicine Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Clearmind Stock often depends not only on the future outlook of the current and potential Clearmind Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clearmind Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 202.5 K | |
| Cash And Short Term Investments | 4 M |
Clearmind Medicine Technical Analysis
Clearmind Medicine's future price can be derived by breaking down and analyzing its technical indicators over time. Clearmind Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Clearmind Medicine Common. In general, you should focus on analyzing Clearmind Stock price patterns and their correlations with different microeconomic environments and drivers.
Clearmind Medicine Predictive Forecast Models
Clearmind Medicine's time-series forecasting models is one of many Clearmind Medicine's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Clearmind Medicine's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Clearmind Medicine Common
Checking the ongoing alerts about Clearmind Medicine for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Clearmind Medicine Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Clearmind Medicine had very high historical volatility over the last 90 days | |
| Clearmind Medicine may become a speculative penny stock | |
| Clearmind Medicine has a very high chance of going through financial distress in the upcoming years | |
| Clearmind Medicine Common currently holds 3.61 M in liabilities. Clearmind Medicine Common has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Clearmind Medicine's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Clearmind Medicine Common currently holds about 1.65 K in cash with (4.56 M) of positive cash flow from operations. | |
| Clearmind Medicine has a frail financial position based on the latest SEC disclosures |
Check out Clearmind Medicine Backtesting, Clearmind Medicine Valuation, Clearmind Medicine Correlation, Clearmind Medicine Hype Analysis, Clearmind Medicine Volatility, Clearmind Medicine History as well as Clearmind Medicine Performance. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Return On Assets (0.58) | Return On Equity (2.68) |
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.